Consensus $2.91. Narrows FY24 adjusted EBITDA view to $356M from $348M-$360M. Lowers FY24 organic sales view to up 1% from up 2%. Sees FY24 capital expenditures 2.5% of net sales. The company said, “In fiscal 2024, the Company is taking specific actions to strengthen its operating model, simplify the organization and improve manufacturing and supply chain efficiency through restructuring and re-positioning actions. As a result of these actions, the Company expects to incur pre-tax charges of approximately $19 million for the full fiscal year.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EPC:
- Edgewell Personal Care Announces Third Quarter Fiscal 2024 Results
- EPC Upcoming Earnings Report: What to Expect?
- Prices of pads, tampons have risen faster than the price of food, WSJ says
- Edgewell Personal Care price target raised to $41 from $40 at Barclays
- Playtex maker ticks lower after UC Berkeley study on tampon toxins